Table 5.

Prognostic power of the ratio of PC (34:2) to PC (30:0) in all studied populations

Population	BHT			ES HCC			LS HCC			p value*
	n	Mean	SD	n	Mean	SD	n	Mean	SD
HCC clinical stage
All	32	1.66	0.57	12	0.62	0.34	16	0.69	0.51	0.0000000028
Female	11	1.85	0.69	5	0.40	0.26	4	0.92	0.46	0.00057
Male	21	1.56	0.48	15	0.59	0.31	4	0.97	0.78	0.0000014
HCC pathological grade
All	32	1.66	0.57	11	0.61	0.39		0.69	0.48	0.0000000028
Female	11	1.85	0.69	4	0.92	0.46	5	0.40	0.26	0.00055
Male	21	1.56	0.48	7	0.44	0.22	12	0.80	0.50	0.0000010045

BHT benign hepatic tissue, HCC hepatocellular carcinoma, ES HCC early-stage HCC, LS HCC late-stage HCC, HG HCC high-grade HCC

*p value was calculated by ANOVA